The Influenza-Induced Pulmonary Inflammatory Exudate in Susceptible Tpl2-Deficient Mice Is Dictated by Type I IFN Signaling
- 13 October 2022
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 46 (1) , 322-341
Abstract
The most prominent host response to viral infection is the production of type 1 interferons (T1 IFNs). One host regulator of the T1 IFNs is the serine-threonine kinase, tumor progression locus 2 (TPL2). We have previously demonstrated that Tpl2−/− mice succumb to infection with a low-pathogenicity influenza A strain (x31), in association with with increased pulmonary levels of interferon-β (IFN-β), chemokine CCL2, and excessive monocyte and neutrophil pulmonary infiltration. TPL2-dependent overexpression of IFN-β has been implicated in enhanced susceptibility to Mycobacterium tuberculosis; therefore, we examined the role of T1 IFNs in susceptibility of Tpl2−/− mice to influenza. CCL2 overexpression and monocyte recruitment were normalized in Ifnar1−/−Tpl2−/− mice, confirming that TPL2 constrains inflammatory monocyte recruitment via inhibition of the T1 IFN/CCL2 axis. Unexpectedly, excessive neutrophil recruitment in Ifnar1−/− strains was further exacerbated by simultaneous TPL2 genetic ablation in Ifnar1−/−Tpl2−/− by 7 dpi, accompanied by overexpression of neutrophil-regulating cytokines, CXCL1 and IFN-λ. Collectively, our data suggest that TPL2 and T1 IFNs synergize to inhibit neutrophil recruitment. However, treatment with the neutrophil-depleting anti-Ly6G antibody showed only a modest improvement in disease. Analysis of sorted innate immune populations revealed redundant expression of inflammatory mediators among neutrophils, inflammatory monocytes and alveolar macrophages. These findings suggest that targeting a single cell type or mediator may be inadequate to control severe disease characterized by a mixed inflammatory exudate. Future studies will consider TPL2-regulated pathways as potential predictors of severe influenza progression as well as investigate novel methods to modulate TPL2 function during viral infection.Keywords
Funding Information
- National Institutes of Health (R21AI147003)
This publication has 72 references indexed in Scilit:
- Tumor Progression Locus 2 Mediates Signal-Induced Increases in Cytoplasmic Calcium and Cell MigrationScience Signaling, 2011
- Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinaseCell Research, 2010
- Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In VivoJournal of Virology, 2010
- Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral InfectionsJournal of Virology, 2010
- The IKK Complex, a Central Regulator of NF- B ActivationCold Spring Harbor Perspectives in Biology, 2009
- TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cellsJournal of Experimental Medicine, 2009
- The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of miceRespiratory Research, 2008
- Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cellsProceedings of the National Academy of Sciences, 2008
- IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis virusesProceedings of the National Academy of Sciences, 2007
- Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.Journal of Clinical Investigation, 1990